Last10K.com

Paratek Pharmaceuticals, Inc. (PRTK) SEC Filing 8-K Material Event for the period ending Thursday, June 27, 2019

Paratek Pharmaceuticals, Inc.

HISTORY TOOLS
CIK: 1516551 Ticker: PRTK

View differences made from one to another to evaluate Paratek Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Paratek Pharmaceuticals, Inc..

Continue

Assess how Paratek Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Paratek Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Paratek Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 1.1: Underwriting Agreement
Exhibit 5.1: Opinion Regarding Legality
Exhibit 10.1: Material Contract
Ticker: PRTK
CIK: 1178711
Form Type: 8-K Corporate News
Accession Number: 0001564590-19-024440
Submitted to the SEC: Tue Jul 02 2019 5:22:45 PM EST
Accepted by the SEC: Tue Jul 02 2019
Period: Thursday, June 27, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. New Agreement
  3. New Financial Obligation
  4. Other Events

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/prtk/0001564590-19-024440.htm